A mechanistic review of the pharmacological potential of narirutin: a dietary flavonoid

Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5449-5461. doi: 10.1007/s00210-024-03022-w. Epub 2024 Mar 8.

Abstract

Flavanones, a type of polyphenol, are found in substantial amounts in citrus fruits. When high- or moderate-dose orange juice consumption occurs, flavanones make up a significant portion of the total polyphenols in plasma. Disaccharide derivative narirutin, mainly dihydroxy flavanone, is found in citrus fruits. The substantial chemotherapeutic potential of narirutin has been amply demonstrated by numerous experimental studies. Consequently, the purpose of this study is to compile the research that has already been done showing narirutin to be a promising anticancer drug, with its mechanism of action being documented in treatment plans for various cancer forms. Narirutin functions in a variety of cancer cells by regulating several pathways that include cell cycle arrest, apoptosis, antiangiogenic, antimetastatic, and DNA repair. Narirutin has been shown to modify many molecular targets linked to the development of cancer, including drug transporters, cell cycle mediators, transcription factors, reactive oxygen species, reactive nitrogen species, and inflammatory cytokines. Taken together, these reviews offer important new information about narirutin's potential as a potent and promising drug candidate for use in medicines, functional foods, dietary supplements, nutraceuticals, and other products targeted at improving the treatment of cancer.

Keywords: Anticancer potential; Citrus; Metabolism; Narirutin; Phytocompound.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Disaccharides
  • Flavanones
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Humans
  • Hydroxyethylrutoside / analogs & derivatives
  • Hydroxyethylrutoside / pharmacology
  • Hydroxyethylrutoside / therapeutic use
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism
  • Neoplasms* / pathology

Substances

  • narirutin
  • Hydroxyethylrutoside
  • Antineoplastic Agents, Phytogenic
  • Flavonoids
  • Antineoplastic Agents
  • Disaccharides
  • Flavanones